Public Radio Programs Discuss New Gardasil Statistics
Main Category: Cervical Cancer / HPV VaccineArticle Date: 21 Aug 2009 - 3:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Two public radio programs recently featured reports on a study released Wednesday examining federal vaccination statistics on Merck's Gardasil, a vaccine that protects against some strains of the human papillomavirus that can lead to cervical cancer and genital warts. The vaccine is approved for girls and young women ages nine to 26 and recommended by the Centers for Disease Control and Prevention. The study found that CDC has received reports of more than 12,000 adverse events, including 20 verified deaths, which could not be definitively linked with the vaccine. Summaries of the radio broadcasts appear below.
~ NPR's "All Things Considered": Wednesday's program included a report on the safety of the vaccine. The segment included comments from study author Barbara Slade, a medical officer in CDC's Immunization Safety Office, and Neal Halsey, a pediatrician and the director of the Institute for Vaccine Safety at Johns Hopkins University. Slade said, "It still appears that the vaccine is safe and that the benefits outweigh the risks." She added that the "benefit is that it will prevent infection with the most common types of [HPV] that cause cervical cancer." Halsey said he is "certain" the vaccine is "by far the safest thing one can do with young children today." He added, "To the best of my knowledge, there's no evidence that any" of the deaths reported in the study "have been causally related to the vaccine" (Wilson, "All Things Considered," NPR, 8/19).
~ PRI's "The Takeaway": Thursday's program included a discussion with Sheila Rothman -- a professor at Columbia University's Mailman School of Public Health who co-authored an analysis of Merck's marketing of Gardasil -- and Diane Harper, a physician and one of the leading researchers for the vaccine's clinical trials. According to "The Takeaway," Harper "has been speaking out in favor of more warnings" on adverse events associated with Gardasil. The segment also featured comments from a woman on whether she plans to have her daughter vaccinated (Hockenberry et al., "The Takeaway," PRI, 8/20).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/161425.php>
APA
http://www.medicalnewstoday.com/releases/161425.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



